Nuveen International Equity Index Fund I Class (TCIHX)
| Fund Assets | 32.21B |
| Expense Ratio | 0.18% |
| Min. Investment | $0.00 |
| Turnover | 9.00% |
| Dividend (ttm) | 1.05 |
| Dividend Yield | 3.58% |
| Dividend Growth | 58.12% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 12, 2025 |
| Previous Close | 29.27 |
| YTD Return | 4.27% |
| 1-Year Return | 22.40% |
| 5-Year Return | 48.06% |
| 52-Week Low | 24.58 |
| 52-Week High | 30.63 |
| Beta (5Y) | n/a |
| Holdings | 712 |
| Inception Date | Dec 4, 2015 |
About TCIHX
Nuveen International Equity Index Fund I is an institutional mutual fund designed to deliver long-term total return through capital appreciation by investing primarily in foreign equity securities. The fund seeks to closely track the performance of the MSCI EAFE Index, a widely recognized benchmark representing large- and mid-cap companies across developed markets outside the United States and Canada. It typically allocates at least 80% of its assets to the equity securities within this index, using a sampling approach to match the overall characteristics of the benchmark. This fund offers exposure to a diverse mix of sectors, including healthcare, technology, consumer goods, and energy, with notable holdings in companies such as Novo Nordisk, ASML Holding, and Nestle. It emphasizes cost efficiency, maintaining a low expense ratio and turnover, making it competitive among its foreign large blend peers. With a global reach spanning at least three countries outside the U.S., the fund serves as a core international equity holding for institutional investors seeking diversified access to developed international markets while aiming to minimize tracking error and expenses.
Performance
TCIHX had a total return of 22.40% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.60%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
16.84% of assets| Name | Symbol | Weight |
|---|---|---|
| Msci Eafe Mar26 Ifus 20260320 | n/a | 3.09% |
| 2026-03-02_3.66 Repo - 02mar26 | n/a | 2.80% |
| ASML Holding N.V. | ASML | 2.36% |
| Roche Holding AG | ROP | 1.40% |
| AstraZeneca PLC | AZN | 1.37% |
| HSBC Holdings plc | HSBA | 1.34% |
| Novartis AG | NOVN | 1.34% |
| Nestlé S.A. | NESN | 1.18% |
| Shell plc | SHEL | 1.00% |
| Toyota Motor Corporation | 7203 | 0.96% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 12, 2025 | $1.04779 | Dec 15, 2025 |
| Dec 6, 2024 | $0.66265 | Dec 9, 2024 |
| Dec 8, 2023 | $0.64696 | Dec 8, 2023 |
| Dec 9, 2022 | $0.51524 | Dec 9, 2022 |
| Dec 10, 2021 | $0.66589 | Dec 10, 2021 |
| Dec 11, 2020 | $0.39561 | Dec 11, 2020 |